The Regulations would encompass the processing and retail sale of cannabinoid hemp in the state. The document covers licensing and application requirements for hemp processors; licensing and application requirements for retailers looking to sell hemp; product, packaging, labeling, and advertising requirements for cannabinoid hemp products to be sold in retail; and testing requirements for the products.
In CRN’s comments, Amanda Darlington, Director of Government Relations, details “CRN’s support for a federal regulatory scheme enacted for hemp-derived CBD dietary supplements, and…the promotion of state laws and regulations regulating hemp-derived CBD dietary supplements in a manner consistent with federal requirements for all dietary supplement products.”
Related: FDA Releases Update on CBD; CRN Calls It an “End-of-Administration Desk-Clearing Exercise” NPA Raises Issues of CBD and Counterfeit Products in Letter to Congress CRN Announces New Chairman and 2021 Board of Directors
Darlington adds that while there is uncertainty at the federal level, CRN is working with Congress to support federal legislation that would recognize CBD as a lawful dietary ingredient to be regulated by FDA, irrespective of hurdles in FDCA, and require CBD products to adhere to the same requirements as any other supplement. “We expect Congress to consider legislation addressing this critical issue early in the 117thsession,” Darlington states, “and strongly encourage states looking to adopt their own hemp-related regulatory structures to fashion ones that would be consistent with that federal framework.”CRN’s comments, with suggested edits to the proposed regulations,can be found here.
